Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Press Releases
Donate Now
MJFF in the News

Press Releases

Browse current and past press releases from The Michael J. Fox Foundation.

 From
To
  • Default content image

    The 2011 NIKE MAG Auction Raises $4.7 Million for The Michael J. Fox Foundation for Parkinson's Research

    NEW YORK—The Michael J. Fox Foundation for Parkinson’s Research (MJFF) today announced that Nike’s total funds raised for the Foundation, generated by the 10-day eBay auction of 1,500 pairs of…
    Learn more
  • Default content image

    MJFF and The Kinetics Foundation Collaborate on Search for Parkinson's Biomarker

    NEW YORK – The Michael J. Fox Foundation for Parkinson’s Research today announced that it is partnering with The Kinetics Foundation to measure the impact of an innovative computer-based device,…
    Learn more
  • Default content image

    Joint Statement by Six Parkinson’s Disease Organizations Regarding Proposed Label Change for Azilect

    Joint Statement by Six Parkinson’s Disease Organizations Regarding Proposed Label Change for AzilectFDA Advisory Committee Meeting This statement is prepared on behalf of the American Parkinson…
    Learn more
  • Default content image

    MJFF Awards AFFiRiS $1.5 Million for the Clinical Development of the First Parkinson's Disease Vaccine

    NEW YORK, USA AND VIENNA, AUSTRIA–The Michael J. Fox Foundation (MJFF) today announced that it has awarded $1.5 million to AFFiRiS AG, a Vienna, Austria-based biotech company, for a clinical study of…
    Learn more
  • Default content image

    MJFF Awardee Builds on Foundation Funding to Land $8 Million Follow-on Award from NINDS

    Last week, Banner Sun Health Research Institute (BSHRI) and Mayo Clinic Arizona announced an $8 million, five-year grant from The National Institute of Neurological Disorders and Stroke (NINDS) to…
    Learn more
  • Default content image

    Vanderbilt-MJFF Partnership Yields Drug-Like Molecules Aimed at Improving Treatment of Parkinson's Disease

    Researchers at Vanderbilt University Medical Center have achieved a milestone in the development of a potential new treatment for Parkinson’s disease that may improve on some of the limitations of…
    Learn more
  • Default content image

    Addex Moving Forward with Phase II Study to Reduce Levodopa-induced Dyskinesia

    Addex Pharmaceuticals is moving forward with a Phase IIa study evaluating the metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator, called dipraglurant (ADX48621), in reducing…
    Learn more
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.
Here. Until Parkinson's isn't.
Join us as we work to find a cure for the 6 million people worldwide living with Parkinson's.
 
 
 
 
Month
Day
Year